Yahoo
NYSE American - Delayed Quote USD

Milestone Scientific Inc. (MLSS)

0.3046 -0.0104 (-3.30%)
At close: October 30 at 4:00:00 PM EDT
0.3061 +0.0015 (+0.49%)
After hours: October 30 at 5:05:00 PM EDT
Chart Range Bar
Loading chart for MLSS
  • Previous Close 0.3150
  • Open 0.3300
  • Bid --
  • Ask --
  • Day's Range 0.3003 - 0.3198
  • 52 Week Range 0.2200 - 0.5800
  • Volume 41,984
  • Avg. Volume 123,000
  • Market Cap (intraday) 27.6M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1.25

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

www.milestonescientific.com

15

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MLSS
12.81%
S&P 500 (^GSPC)
10.73%

1-Year Return

MLSS
27.48%
S&P 500 (^GSPC)
11.11%

3-Year Return

MLSS
66.16%
S&P 500 (^GSPC)
81.91%

5-Year Return

MLSS
85.21%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 2.16M
Earnings -839.85k
Profit Margin -38.85%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-1M
0
1M
2M
-60.0%
-55.0%
-50.0%
-45.0%
-40.0%

Analyst Insights

View More

Analyst Price Targets

1.00
1.25 Average
0.3046 Current
1.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/20/2025
Analyst Benchmark
Rating Action Maintains
Rating Speculative Buy
Price Action Lowers
Price Target 1.25 -> 1

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -43.98%

  • Return on Assets (ttm)

    -31.28%

  • Return on Equity (ttm)

    -121.67%

  • Revenue (ttm)

    9.42M

  • Net Income Avi to Common (ttm)

    -4.14M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.07M

  • Total Debt/Equity (mrq)

    17.74%

  • Levered Free Cash Flow (ttm)

    981.64k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: